Page last updated: 2024-08-07 15:52:25
Retinoic acid receptor alpha
A retinoic acid receptor alpha that is encoded in the genome of human. [PRO:DNx, UniProtKB:P10276]
Synonyms
RAR-alpha;
Nuclear receptor subfamily 1 group B member 1
Research
Bioassay Publications (49)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 19 (38.78) | 18.2507 |
2000's | 16 (32.65) | 29.6817 |
2010's | 13 (26.53) | 24.3611 |
2020's | 1 (2.04) | 2.80 |
Compounds (36)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
am 580 | Homo sapiens (human) | IC50 | 0.0410 | 1 | 1 |
lg 100268 | Homo sapiens (human) | Ki | 2.1475 | 2 | 2 |
adapalene | Homo sapiens (human) | Ki | 1.1000 | 1 | 1 |
bexarotene | Homo sapiens (human) | Ki | 2.8165 | 2 | 2 |
tamibarotene | Homo sapiens (human) | IC50 | 0.0780 | 1 | 1 |
tamibarotene | Homo sapiens (human) | Ki | 0.0065 | 1 | 1 |
4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid | Homo sapiens (human) | Ki | 0.0053 | 1 | 1 |
cd 437 | Homo sapiens (human) | Ki | 6.5000 | 1 | 1 |
6-(1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-naphthyl)-2-naphthalenecarboxylic acid | Homo sapiens (human) | Ki | 0.5800 | 1 | 1 |
cd 2019 | Homo sapiens (human) | Ki | 1.1200 | 1 | 1 |
agn 193109 | Homo sapiens (human) | IC50 | 0.0310 | 1 | 1 |
tretinoin | Homo sapiens (human) | IC50 | 2.2542 | 4 | 4 |
tretinoin | Homo sapiens (human) | Ki | 0.0688 | 3 | 3 |
bms 195614 | Homo sapiens (human) | Ki | 0.0018 | 1 | 2 |
bms 961 | Homo sapiens (human) | Ki | 0.0015 | 1 | 1 |
alitretinoin | Homo sapiens (human) | IC50 | 0.0070 | 1 | 1 |
alitretinoin | Homo sapiens (human) | Ki | 0.0223 | 1 | 1 |
lg 100567 | Homo sapiens (human) | Ki | 0.0323 | 1 | 2 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | Homo sapiens (human) | IC50 | 0.0360 | 1 | 1 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | Homo sapiens (human) | Ki | 0.0210 | 1 | 1 |
pregna-4,17-diene-3,16-dione | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
lg100754 | Homo sapiens (human) | Ki | 1.7910 | 1 | 1 |
lg 1506 | Homo sapiens (human) | Ki | 0.5270 | 2 | 2 |
bms453 | Homo sapiens (human) | Ki | 0.0077 | 1 | 1 |
hx 630 | Homo sapiens (human) | Ki | 0.9000 | 1 | 1 |
bms 204493 | Homo sapiens (human) | IC50 | 0.1140 | 1 | 1 |
le 135 | Homo sapiens (human) | Ki | 1.4000 | 1 | 1 |
Drugs with Activation Measurements
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
am 580 | Homo sapiens (human) | EC30 | 0.0003 | 1 | 1 |
am 580 | Homo sapiens (human) | ED30 | 0.0003 | 1 | 1 |
lg 100268 | Homo sapiens (human) | Synergy | 0.0069 | 1 | 1 |
tamibarotene | Homo sapiens (human) | EC30 | 0.0013 | 1 | 1 |
tamibarotene | Homo sapiens (human) | ED30 | 0.0007 | 1 | 1 |
6-(1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-naphthyl)-2-naphthalenecarboxylic acid | Homo sapiens (human) | AC50 | 1.0000 | 1 | 1 |
tretinoin | Homo sapiens (human) | EC30 | 0.0010 | 2 | 2 |
tretinoin | Homo sapiens (human) | Relative EC30 | 0.0022 | 2 | 2 |
tretinoin | Homo sapiens (human) | Relative IC50 | 0.0009 | 2 | 2 |
alitretinoin | Homo sapiens (human) | AC50 | 0.0190 | 1 | 1 |
sr 11217 | Homo sapiens (human) | AC50 | 1.0000 | 1 | 1 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | Homo sapiens (human) | AC50 | 0.2000 | 1 | 1 |
nrx 194204 | Homo sapiens (human) | Synergy | 0.0019 | 1 | 1 |
Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents.Journal of medicinal chemistry, , Feb-10, Volume: 54, Issue:3, 2011
Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands.Journal of medicinal chemistry, , Mar-26, Volume: 52, Issue:6, 2009
Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 19, Issue:2, 2009
Synthesis and biological activity of retinoic acid receptor-alpha specific amides.Bioorganic & medicinal chemistry letters, , Nov-04, Volume: 12, Issue:21, 2002
Syntheses and structure-activity relationships of 5,6,7, 8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline derivatives with retinoic acid receptor alpha agonistic activity.Journal of medicinal chemistry, , Feb-10, Volume: 43, Issue:3, 2000
Identification of a retinoic acid receptor alpha subtype specific agonist.Journal of medicinal chemistry, , Aug-02, Volume: 39, Issue:16, 1996
Design, synthesis and structure-activity relationship of novel RXR-selective modulators.Bioorganic & medicinal chemistry letters, , Mar-22, Volume: 14, Issue:6, 2004
Design and synthesis of novel RXR-selective modulators with improved pharmacological profile.Bioorganic & medicinal chemistry letters, , Nov-17, Volume: 13, Issue:22, 2003
Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne.Bioorganic & medicinal chemistry letters, , 06-01, Volume: 28, Issue:10, 2018
Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes.Journal of medicinal chemistry, , Dec-22, Volume: 38, Issue:26, 1995
Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry.Journal of medicinal chemistry, , 03-22, Volume: 61, Issue:6, 2018
Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells.Journal of medicinal chemistry, , Feb-25, Volume: 42, Issue:4, 1999
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.Journal of medicinal chemistry, , Dec-19, Volume: 40, Issue:26, 1997
Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.Journal of medicinal chemistry, , Sep-02, Volume: 37, Issue:18, 1994
Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.Journal of medicinal chemistry, , Oct-14, Volume: 53, Issue:19, 2010
Syntheses and structure-activity relationships of 5,6,7, 8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline derivatives with retinoic acid receptor alpha agonistic activity.Journal of medicinal chemistry, , Feb-10, Volume: 43, Issue:3, 2000
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.Journal of medicinal chemistry, , Dec-19, Volume: 40, Issue:26, 1997
Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne.Bioorganic & medicinal chemistry letters, , 06-01, Volume: 28, Issue:10, 2018
Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes.Journal of medicinal chemistry, , Dec-22, Volume: 38, Issue:26, 1995
4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor alpha agonists.Bioorganic & medicinal chemistry letters, , Jun-19, Volume: 10, Issue:12, 2000
Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes.Journal of medicinal chemistry, , Dec-22, Volume: 38, Issue:26, 1995
Phenylcyclohexene and phenylcyclohexadiene substituted compounds having retinoid antagonist activity.Bioorganic & medicinal chemistry letters, , Mar-26, Volume: 11, Issue:6, 2001
High affinity retinoic acid receptor antagonists: analogs of AGN 193109.Bioorganic & medicinal chemistry letters, , Feb-22, Volume: 9, Issue:4, 1999
Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors.Journal of medicinal chemistry, , Nov-24, Volume: 38, Issue:24, 1995
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation.Journal of medicinal chemistry, , 02-28, Volume: 62, Issue:4, 2019
Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool.MedChemComm, , Aug-01, Volume: 10, Issue:8, 2019
Probing biological activity through structural modelling of ligand-receptor interactions of 2,4-disubstituted thiazole retinoids.Bioorganic & medicinal chemistry, , 05-01, Volume: 26, Issue:8, 2018
Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist.Bioorganic & medicinal chemistry, , 02-15, Volume: 26, Issue:4, 2018
Design, synthesis and evaluation of retinoids with novel bulky hydrophobic partial structures.Bioorganic & medicinal chemistry, , Jul-15, Volume: 21, Issue:14, 2013
Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands.Journal of medicinal chemistry, , Mar-26, Volume: 52, Issue:6, 2009
Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 19, Issue:2, 2009
Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice.Journal of medicinal chemistry, , Dec-30, Volume: 47, Issue:27, 2004
Retinoic acid receptor ligands based on the 6-cyclopropyl-2,4-hexadienoic acid.Bioorganic & medicinal chemistry letters, , Jan-20, Volume: 13, Issue:2, 2003
Synthesis and biological activity of retinoic acid receptor-alpha specific amides.Bioorganic & medicinal chemistry letters, , Nov-04, Volume: 12, Issue:21, 2002
Phenylcyclohexene and phenylcyclohexadiene substituted compounds having retinoid antagonist activity.Bioorganic & medicinal chemistry letters, , Mar-26, Volume: 11, Issue:6, 2001
Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.Journal of molecular biology, , Sep-08, Volume: 302, Issue:1, 2000
Novel retinoic acid receptor alpha agonists: syntheses and evaluation of pyrazole derivatives.Bioorganic & medicinal chemistry letters, , Apr-03, Volume: 10, Issue:7, 2000
Discovery of novel and potent retinoic acid receptor alpha agonists: syntheses and evaluation of benzofuranyl-pyrrole and benzothiophenyl-pyrrole derivatives.Journal of medicinal chemistry, , Jul-27, Volume: 43, Issue:15, 2000
Syntheses and evaluation of naphthalenyl- and chromenyl-pyrrolyl-benzoic acids as potent and selective retinoic acid receptor alpha agonists.Bioorganic & medicinal chemistry letters, , Apr-03, Volume: 10, Issue:7, 2000
Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands.Bioorganic & medicinal chemistry letters, , Feb-22, Volume: 9, Issue:4, 1999
High affinity retinoic acid receptor antagonists: analogs of AGN 193109.Bioorganic & medicinal chemistry letters, , Feb-22, Volume: 9, Issue:4, 1999
Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid.Journal of medicinal chemistry, , Dec-02, Volume: 42, Issue:24, 1999
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.Journal of medicinal chemistry, , Dec-19, Volume: 40, Issue:26, 1997
Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids.Journal of medicinal chemistry, , Jun-07, Volume: 39, Issue:12, 1996
Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.Journal of medicinal chemistry, , Aug-30, Volume: 39, Issue:18, 1996
Identification of a retinoic acid receptor alpha subtype specific agonist.Journal of medicinal chemistry, , Aug-02, Volume: 39, Issue:16, 1996
Identification of retinoic acid receptor beta subtype specific agonists.Journal of medicinal chemistry, , Dec-20, Volume: 39, Issue:26, 1996
Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.Journal of medicinal chemistry, , Jul-05, Volume: 39, Issue:14, 1996
Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors.Journal of medicinal chemistry, , Nov-24, Volume: 38, Issue:24, 1995
Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes.Journal of medicinal chemistry, , Dec-22, Volume: 38, Issue:26, 1995
Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.Journal of medicinal chemistry, , Jul-21, Volume: 38, Issue:15, 1995
Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.Journal of medicinal chemistry, , Feb-04, Volume: 37, Issue:3, 1994
Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.Journal of medicinal chemistry, , Sep-03, Volume: 36, Issue:18, 1993
Discovery of (Journal of medicinal chemistry, , 07-28, Volume: 65, Issue:14, 2022
Retinoic acid receptor ligands based on the 6-cyclopropyl-2,4-hexadienoic acid.Bioorganic & medicinal chemistry letters, , Jan-20, Volume: 13, Issue:2, 2003
Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.Journal of medicinal chemistry, , Jul-05, Volume: 44, Issue:14, 2001
Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.Journal of molecular biology, , Sep-08, Volume: 302, Issue:1, 2000
sp2-bridged diaryl retinoids: effects of bridge-region substitution on retinoid X receptor (RXR) selectivity.Bioorganic & medicinal chemistry letters, , Jun-19, Volume: 10, Issue:12, 2000
Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid.Journal of medicinal chemistry, , Dec-02, Volume: 42, Issue:24, 1999
Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands.Bioorganic & medicinal chemistry letters, , Feb-22, Volume: 9, Issue:4, 1999
Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.Journal of medicinal chemistry, , Aug-30, Volume: 39, Issue:18, 1996
Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.Journal of medicinal chemistry, , Jul-05, Volume: 39, Issue:14, 1996
Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity.Journal of medicinal chemistry, , Aug-18, Volume: 38, Issue:17, 1995
Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.Journal of medicinal chemistry, , Jul-21, Volume: 38, Issue:15, 1995
Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.Journal of medicinal chemistry, , Feb-04, Volume: 37, Issue:3, 1994
Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.Journal of medicinal chemistry, , Sep-03, Volume: 36, Issue:18, 1993
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 24, Issue:22, 2014
4-[3-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor alpha agonists.Bioorganic & medicinal chemistry letters, , Jun-19, Volume: 10, Issue:12, 2000
Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes.Journal of medicinal chemistry, , Dec-22, Volume: 38, Issue:26, 1995
Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.Journal of medicinal chemistry, , Jul-21, Volume: 38, Issue:15, 1995
Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.Journal of medicinal chemistry, , Feb-04, Volume: 37, Issue:3, 1994
Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.Journal of medicinal chemistry, , Sep-03, Volume: 36, Issue:18, 1993
Design, synthesis and structure-activity relationship of novel RXR-selective modulators.Bioorganic & medicinal chemistry letters, , Mar-22, Volume: 14, Issue:6, 2004
Design and synthesis of novel RXR-selective modulators with improved pharmacological profile.Bioorganic & medicinal chemistry letters, , Nov-17, Volume: 13, Issue:22, 2003
Design and synthesis of novel RXR-selective modulators with improved pharmacological profile.Bioorganic & medicinal chemistry letters, , Nov-17, Volume: 13, Issue:22, 2003
Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.Journal of medicinal chemistry, , Jul-05, Volume: 44, Issue:14, 2001
Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne.Bioorganic & medicinal chemistry letters, , 06-01, Volume: 28, Issue:10, 2018
Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.Journal of molecular biology, , Sep-08, Volume: 302, Issue:1, 2000
Enables
This protein enables 24 target(s):
Target | Category | Definition |
mRNA regulatory element binding translation repressor activity | molecular function | Antagonizes the ribosome-mediated translation of mRNA into a polypeptide via direct binding (through a selective and non-covalent interaction) to nucleic acid. [GOC:clt, GOC:vw, PMID:29061112, PMID:7523370] |
RNA polymerase II transcription regulatory region sequence-specific DNA binding | molecular function | Binding to a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II. [GOC:txnOH] |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | molecular function | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. [GOC:txnOH-2018] |
DNA-binding transcription factor activity, RNA polymerase II-specific | molecular function | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. [GOC:txnOH-2018] |
DNA-binding transcription repressor activity | molecular function | A DNA-binding transcription factor activity that represses or decreases the transcription of specific gene sets. [GOC:txnOH-2018] |
transcription coactivator binding | molecular function | Binding to a transcription coactivator, a protein involved in positive regulation of transcription via protein-protein interactions with transcription factors and other proteins that positively regulate transcription. Transcription coactivators do not bind DNA directly, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery. [GOC:krc] |
retinoic acid binding | molecular function | Binding to retinoic acid, 3,7-dimethyl-9-(2,6,-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid. [GOC:hjd] |
chromatin binding | molecular function | Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. [GOC:jl, ISBN:0198506732, PMID:20404130] |
DNA-binding transcription factor activity | molecular function | A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons. [GOC:txnOH-2018] |
nuclear receptor activity | molecular function | A DNA-binding transcription factor activity regulated by binding to a ligand that modulates the transcription of specific gene sets transcribed by RNA polymerase II. Nuclear receptor ligands are usually lipid-based (such as a steroid hormone) and the binding of the ligand to its receptor often occurs in the cytosol, which leads to its translocation to the nucleus. [GOC:txnOH-2018, PMID:23457262] |
signaling receptor binding | molecular function | Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. [GOC:bf, GOC:ceb, ISBN:0198506732] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
zinc ion binding | molecular function | Binding to a zinc ion (Zn). [GOC:ai] |
enzyme binding | molecular function | Binding to an enzyme, a protein with catalytic activity. [GOC:jl] |
protein domain specific binding | molecular function | Binding to a specific domain of a protein. [GOC:go_curators] |
chromatin DNA binding | molecular function | Binding to DNA that is assembled into chromatin. [GOC:mah] |
histone deacetylase binding | molecular function | Binding to histone deacetylase. [GOC:jl] |
protein kinase B binding | molecular function | Binding to protein kinase B, an intracellular kinase that is important in regulating glucose metabolism. [GOC:jl, http://www.heartandmetabolism.org/] |
retinoic acid-responsive element binding | molecular function | Binding to a retinoic acid-responsive element, a variable direct repeat of the sequence PuGGTCA spaced by five nucleotides (DR5) found in the promoters of retinoic acid-responsive genes, to which retinoic acid receptors bind. [GOC:jl, GOC:vw, GOC:yaf, PMID:11327309, PMID:19917671] |
mRNA 5'-UTR binding | molecular function | Binding to an mRNA molecule at its 5' untranslated region. [GOC:jid] |
protein kinase A binding | molecular function | Binding to a protein kinase A. [GOC:ai] |
alpha-actinin binding | molecular function | Binding to alpha-actinin, one of a family of proteins that cross-link F-actin as antiparallel homodimers. Alpha-actinin has a molecular mass of 93-103 KDa; at the N-terminus there are two calponin homology domains, at the C-terminus there are two EF-hands. These two domains are connected by the rod domain. This domain is formed by triple-helical spectrin repeats. [PMID:10984498, PMID:11699871, PMID:15014165] |
heterocyclic compound binding | molecular function | Binding to heterocyclic compound. [GOC:TermGenie] |
sequence-specific double-stranded DNA binding | molecular function | Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding. [GOC:dos, GOC:sl] |
Located In
This protein is located in 9 target(s):
Target | Category | Definition |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
nucleolus | cellular component | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. [ISBN:0198506732] |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
actin cytoskeleton | cellular component | The part of the cytoskeleton (the internal framework of a cell) composed of actin and associated proteins. Includes actin cytoskeleton-associated complexes. [GOC:jl, ISBN:0395825172, ISBN:0815316194] |
dendrite | cellular component | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. [GOC:aruk, GOC:bc, GOC:dos, GOC:mah, GOC:nln, ISBN:0198506732] |
perinuclear region of cytoplasm | cellular component | Cytoplasm situated near, or occurring around, the nucleus. [GOC:jid] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
Part Of
This protein is part of 4 target(s):
Target | Category | Definition |
transcription regulator complex | cellular component | A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. [GOC:jl] |
RNA polymerase II transcription regulator complex | cellular component | A transcription factor complex that acts at a regulatory region of a gene transcribed by RNA polymerase II. [GOC:tb] |
chromatin | cellular component | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130] |
protein-containing complex | cellular component | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. [GOC:dos, GOC:mah] |
Involved In
This protein is involved in 54 target(s):
Target | Category | Definition |
ureteric bud development | biological process | The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure. [GOC:go_curators] |
neural tube closure | biological process | The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline. [GOC:dph, ISBN:0878932437] |
liver development | biological process | The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes. [GOC:add, ISBN:068340007X] |
glandular epithelial cell development | biological process | The process whose specific outcome is the progression of a glandular epithelial cell over time, from its formation to the mature structure. A glandular epithelial cell is a columnar/cuboidal epithelial cell is a cell found in a two dimensional sheet with a free surface exposed to the lumen of a gland. [GOC:dph] |
growth plate cartilage development | biological process | The process whose specific outcome is the progression of the cartilage that will provide a scaffold for mineralization of endochondral bones as they elongate or grow. [GOC:ascb_2009, GOC:dph, GOC:tb] |
protein phosphorylation | biological process | The process of introducing a phosphate group on to a protein. [GOC:hb] |
germ cell development | biological process | The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism. [GOC:go_curators] |
female pregnancy | biological process | The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. [ISBN:0192800825] |
positive regulation of cell population proliferation | biological process | Any process that activates or increases the rate or extent of cell proliferation. [GOC:go_curators] |
negative regulation of cell population proliferation | biological process | Any process that stops, prevents or reduces the rate or extent of cell proliferation. [GOC:go_curators] |
negative regulation of translation | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. [GOC:isa_complete] |
hippocampus development | biological process | The progression of the hippocampus over time from its initial formation until its mature state. [GO_REF:0000021, GOC:cls, GOC:dgh, GOC:dph, GOC:jid, ISBN:0878937420, UBERON:0002421] |
prostate gland development | biological process | The process whose specific outcome is the progression of the prostate gland over time, from its formation to the mature structure. The prostate gland is a partly muscular, partly glandular body that is situated near the base of the mammalian male urethra and secretes an alkaline viscid fluid which is a major constituent of the ejaculatory fluid. [PMID:11839751] |
negative regulation of granulocyte differentiation | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of granulocyte differentiation. [GOC:mah] |
embryonic camera-type eye development | biological process | The process occurring during the embryonic phase whose specific outcome is the progression of the eye over time, from its formation to the mature structure. [GOC:mah, GOC:mtg_sensu] |
regulation of myelination | biological process | Any process that modulates the frequency, rate or extent of the formation of a myelin sheath around nerve axons. [GOC:mah] |
response to estradiol | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. [GOC:mah, ISBN:0911910123] |
response to retinoic acid | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. [GOC:sl] |
negative regulation of type II interferon production | biological process | Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. [GOC:add, GOC:mah, PMID:15546383] |
negative regulation of tumor necrosis factor production | biological process | Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production. [GOC:mah, PMID:10891884, PMID:15560120] |
positive regulation of interleukin-13 production | biological process | Any process that activates or increases the frequency, rate, or extent of interleukin-13 production. [GOC:mah] |
positive regulation of interleukin-4 production | biological process | Any process that activates or increases the frequency, rate, or extent of interleukin-4 production. [GOC:mah] |
positive regulation of interleukin-5 production | biological process | Any process that activates or increases the frequency, rate, or extent of interleukin-5 production. [GOC:mah] |
response to vitamin A | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin A stimulus. [GOC:sl] |
response to cytokine | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus. [GOC:sl] |
multicellular organism growth | biological process | The increase in size or mass of an entire multicellular organism, as opposed to cell growth. [GOC:bf, GOC:curators, GOC:dph, GOC:tb] |
mRNA transcription by RNA polymerase II | biological process | The cellular synthesis of messenger RNA (mRNA) from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. [GOC:jl, ISBN:0321000382] |
regulation of apoptotic process | biological process | Any process that modulates the occurrence or rate of cell death by apoptotic process. [GOC:jl, GOC:mtg_apoptosis] |
apoptotic cell clearance | biological process | The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte. [GOC:rk, PMID:14685684] |
response to ethanol | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. [GOC:go_curators] |
positive regulation of T-helper 2 cell differentiation | biological process | Any process that activates or increases the frequency, rate or extent of T-helper 2 cell differentiation. [GOC:go_curators] |
positive regulation of neuron differentiation | biological process | Any process that activates or increases the frequency, rate or extent of neuron differentiation. [GOC:go_curators] |
positive regulation of cell cycle | biological process | Any process that activates or increases the rate or extent of progression through the cell cycle. [GOC:go_curators] |
negative regulation of DNA-templated transcription | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. [GOC:go_curators, GOC:txnOH] |
positive regulation of DNA-templated transcription | biological process | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. [GOC:go_curators, GOC:txnOH] |
positive regulation of transcription by RNA polymerase II | biological process | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. [GOC:go_curators, GOC:txnOH] |
regulation of synaptic plasticity | biological process | A process that modulates synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers. [GOC:dph, GOC:jid, GOC:tb, PMID:11891290] |
retinoic acid receptor signaling pathway | biological process | The series of molecular signals generated as a consequence of a retinoic acid receptor binding to one of its physiological ligands. [GOC:dgh] |
positive regulation of binding | biological process | Any process that activates or increases the rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule. [GOC:ai] |
ventricular cardiac muscle cell differentiation | biological process | The process in which a relatively unspecialized cell acquires specialized features of a ventricular cardiac muscle cell. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction. The ventricle is the part of the heart that pumps blood out of the organ. [GOC:devbiol, GOC:mtg_heart] |
Sertoli cell fate commitment | biological process | The process in which the cellular identity of Sertoli cells is acquired and determined. [GOC:dph] |
limb development | biological process | The process whose specific outcome is the progression of a limb over time, from its formation to the mature structure. A limb is an appendage of an animal used for locomotion or grasping. Examples include legs, arms or some types of fin. [GOC:dgh, GOC:dph, PMID:11487378] |
face development | biological process | The biological process whose specific outcome is the progression of a face from an initial condition to its mature state. The face is the ventral division of the head. [GOC:dph] |
trachea cartilage development | biological process | The process whose specific outcome is the progression of the tracheal cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate. [GOC:dph] |
chondroblast differentiation | biological process | The process in which a mesenchymal cell, acquires specialized structural and/or functional features of a chondroblast. Differentiation includes the processes involved in commitment of a cell to a chondroblast fate. A chondroblast is a precursor cell to chondrocytes. [GOC:dph] |
negative regulation of cartilage development | biological process | Any process that decreases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate. [GOC:dph] |
cellular response to lipopolysaccharide | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. [GOC:mah] |
cellular response to retinoic acid | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. [GOC:mah] |
cellular response to estrogen stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics. [GOC:mah] |
regulation of hematopoietic progenitor cell differentiation | biological process | Any process that modulates the frequency, rate or extent of hematopoietic progenitor cell differentiation. [GOC:BHF, GOC:rl, GOC:TermGenie] |
negative regulation of miRNA transcription | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of microRNA (miRNA) gene transcription. [GO_REF:0000058, GOC:dph, GOC:kmv, GOC:TermGenie, PMID:24699545] |
cell differentiation | biological process | The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. [ISBN:0198506732] |
hormone-mediated signaling pathway | biological process | The series of molecular signals mediated by the detection of a hormone. [GOC:sm] |
negative regulation of transcription by RNA polymerase II | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. [GOC:go_curators, GOC:txnOH] |